Pfizer and BioNTech Submit Data on Vaccine for Kids 5 to 11

NYT > Top Stories Sharon LaFraniere, Shashank Bengali and Noah WeilandThe companies said that their vaccine was safe and effective in that age group, and that they would submit a formal request in the coming weeks to U.S. regulators to allow a pediatric dose. September 29, 2021 at 12:33AM https://ift.tt/39K2A7B